Exactech, Inc. (EXAC)

Check out top investors' recommendation for EXAC
Last closing price (Nov 25 4:00 EDT):
22.16 (0.41%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
-6.10% ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
N/A
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
N/A
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Exactech, Inc. develops, manufactures, markets, and distributes orthopedic implant devices; and related surgical instrumentation, supplies, and biologic materials to hospitals and physicians in the United States and internationally. It offers knee implant systems that address orthopedic surgeons’ concerns for contact stress, patellar tracking, polyethylene wear, joint stability, bone preservation, and instrumentation; and hip implant systems that address hip arthroplasty, hip fractures, and complex primary hip surgeries. The company also offers biologics and spine products for the healing and regeneration of bone and soft tissues; distributes allograft tissue implants for oral and dental applications; and markets tri-calcium phosphate/hydroxyapatite based synthetic bone graft substitutes. In addition, it offers Ossigen, a 3D matrix of collagen and an organic bone mineral processed into blocks for surgical implantation for the repair of bony defects in the spine, extremities, and pelvis; shoulder systems for the treatment of degenerative disease and trauma; hip, knee, and shoulder spacers that are used in two stage revision procedures; an air-driven impact handpiece that surgeons could use during joint implant revision procedures to remove failed prostheses and bone cement; and bone cement systems. The company markets its orthopedic implant products through a network of independent sales agencies, direct sales representatives, and independent distributors to hospitals, surgeons and other physicians, and clinics. Exactech, Inc. was founded in 1985 and is headquartered in Gainesville, Florida.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
William Plovanic Canaccord Genuity Buy   Jul 25, '13   21.90  29.00  Jul 25, '14  6.30% 
James Terwilliger The Benchmark Company Buy   Feb 27, '13   18.98  22.00  Feb 27, '14  21.76% 
James Terwilliger The Benchmark Company Buy   Sep 13, '12   17.36  21.00  Sep 13, '13  20.97% 
James Terwilliger The Benchmark Company Buy   May 17, '12   16.50  21.00  May 17, '13  9.09%